VCRE
Vicore Pharma Holding AB
9.40$
-0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Vicore Pharma Holding AB (VCRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -376 million SEK. Tick rows to compare them in a chart.
All figures in millions of SEK.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -300 | -250 | -165 | -376 | |
| 3.6 | 3.4 | 2.2 | 0.0 | |
| -21 | -11 | -1.8 | 41 | |
| 3.0 | 0.0 | 0.0 | 0.0 | |
| -39 | 77 | 818 | -546 | |
| -303 | -250 | -165 | -376 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.